Neimeth International Pharmaceuticals Plc (NGSE: NEIMETH)
Health Care · Pharmaceuticals · NG
₦8.00
-6.43% today · +21.2% 1Y
Neimeth International Pharmaceuticals Plc (NGSE: NEIMETH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $25.38M.
Over the last twelve months the share price has gained 21.2%, trading between 4.95 and 16.15.
Tweenvest scores Neimeth International Pharmaceuticals Plc across four factors: quality 55/100, value 39/100, growth 69/100. Its strongest factor is growth.
NEIMETH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.38M
- Revenue (TTM)
- $5.88M
- P/E
- 34.88
- EPS
- 0.23
- Dividend yield
- —
- Beta (5Y)
- 0.70
- 52-week high
- ₦16.15
- 52-week low
- ₦4.95
- Avg volume (3M)
- —
- Shares outstanding
- 4.27B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.70 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.02 | -0.74% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.20 | +0.36% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.